Straits Times Index
3,302.65 +9.72 (+0.30%) Nikkei
38,236.07 -38.03 (-0.10%) Hang Seng
18,505.21 +29.29 (+0.16%) FTSE 100
8,213.49 +41.34 (+0.51%) Bitcoin USD
64,458.74 +1,055.72 (+1.67%) CMC Crypto 200
1,369.84 +57.21 (+4.36%)
Autolus Therapeutics plc (AUTL)
After hours:
| Previous close | 4.1100 |
| Open | 4.2200 |
| Bid | 4.1700 x 1300 |
| Ask | 4.2000 x 800 |
| Day's range | 4.0550 - 4.3600 |
| 52-week range | 1.7900 - 7.4500 |
| Volume | |
| Avg. volume | 1,896,358 |
| Market cap | 1.114B |
| Beta (5Y monthly) | 1.93 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -1.2000 |
| Earnings date | 14 May 2024 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | 10.69 |
Simply Wall St.Recent 13% pullback isn't enough to hurt long-term Autolus Therapeutics (NASDAQ:AUTL) shareholders, they're still up 157% over 1 year
Autolus Therapeutics plc ( NASDAQ:AUTL ) shareholders might be rather concerned because the share price has dropped 33...
GlobeNewswireAbstract for longer-term follow-up and additional data analysis of Pivotal Phase 2 FELIX study of obe-cel for adult r/r B-ALL selected for an oral presentation at ASCO
LONDON, April 24, 2024 (GLOBE NEWSWIRE) -- Autolus Therapeutics plc (Nasdaq: AUTL), a clinical-stage biopharmaceutical company developing next-generation programmed T cell therapies, today announces that the abstract for longer-term follow-up and additional data analysis from the pivotal Phase 2 FELIX study of obecabtagene autoleucel (obe-cel) in relapsed/refractory (r/r) adult B-cell Acute Lymphoblastic Leukemia (ALL) was selected for an oral presentation at the 2024 American Society of Clinica
- GlobeNewswire
Autolus Therapeutics to Report First Quarter 2024 Financial Results and Host Conference Call on May 14, 2024
LONDON, April 23, 2024 (GLOBE NEWSWIRE) -- Autolus Therapeutics plc (Nasdaq: AUTL), a clinical-stage biopharmaceutical company developing next-generation programmed T cell therapies, today announced that it will release its first quarter 2024 financial results and operational highlights before open of US markets on Tuesday, May 14, 2024. Management will host a conference call and webcast at 8:30 am EDT/1:30 pm BST to discuss the company’s financial results and provide a general business update.
